| |
 |
|
Class Information
Number: 514/13
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > 16 to 24 peptide repeating units in known peptide chain
Description: Subject matter which contains as uninterrupted peptide chain of 16 to 24 peptide units.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6835382 |
Ii peptide therapeutics to enhance antigen presentation |
Dec. 28, 2004 |
| 6835536 |
Antimicrobial cationic peptides and formulations thereof |
Dec. 28, 2004 |
| 6821948 |
Conjugate for mediating cell, compartment or membrane-specific transport of active substances |
Nov. 23, 2004 |
| 6821950 |
Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors |
Nov. 23, 2004 |
| 6818217 |
Immunoreactive peptides |
Nov. 16, 2004 |
| 6818405 |
Therapeutic use of the SMR1 protein and active derivatives thereof |
Nov. 16, 2004 |
| 6818616 |
Neutrophil inhibitors |
Nov. 16, 2004 |
| 6818617 |
EC-3, an inhibitor of .alpha.4.beta.1 and .alpha.4.beta.7 integrins |
Nov. 16, 2004 |
| 6818619 |
Chimeric natriuretic peptides |
Nov. 16, 2004 |
| 6815416 |
Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
Nov. 9, 2004 |
| 6815421 |
Polypeptides for use in ameliorating effects of aging in mammals |
Nov. 9, 2004 |
| 6806255 |
Compounds and methods for modulating adhesion molecule function |
Oct. 19, 2004 |
| 6794357 |
Compositions for inhalation |
Sep. 21, 2004 |
| 6790447 |
Peptides for treatment of autoimmune diseases |
Sep. 14, 2004 |
| 6787354 |
Methods for the early diagnosis of ovarian cancer |
Sep. 7, 2004 |
| 6783946 |
Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides |
Aug. 31, 2004 |
| 6784155 |
Inhibitor and stimulator of stem cell proliferation and uses thereof |
Aug. 31, 2004 |
| 6784157 |
Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
Aug. 31, 2004 |
| 6780844 |
Calcium phosphopeptide complexes |
Aug. 24, 2004 |
| 6780847 |
Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
Aug. 24, 2004 |
| 6770281 |
B-cell epitope peptides of HSP 65 |
Aug. 3, 2004 |
| 6770626 |
Tissue remodeling |
Aug. 3, 2004 |
| 6770628 |
Hematopoietic stimulation |
Aug. 3, 2004 |
| 6761890 |
Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vacci |
Jul. 13, 2004 |
| 6759046 |
Peptides |
Jul. 6, 2004 |
| 6759234 |
Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response |
Jul. 6, 2004 |
| 6759387 |
Compositions and methods for enhancing drug delivery across and into epithelial tissues |
Jul. 6, 2004 |
| 6756206 |
Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides |
Jun. 29, 2004 |
| 6756356 |
Compounds and methods for modulating claudin-mediated functions |
Jun. 29, 2004 |
| 6753313 |
Multimeric Apoa-I agonist compounds |
Jun. 22, 2004 |
| 6750200 |
M2GlyR derived channel forming peptides |
Jun. 15, 2004 |
| 6747007 |
Antimicrobial peptides and methods of use thereof |
Jun. 8, 2004 |
| 6743769 |
Antimicrobial peptides and derived metapeptides |
Jun. 1, 2004 |
| 6743778 |
Apo-AI/AII peptide derivatives |
Jun. 1, 2004 |
| 6737406 |
Cryptic peptides and method for their identification |
May. 18, 2004 |
| 6737407 |
Treatment of obesity |
May. 18, 2004 |
| 6734166 |
Method of reducing aluminum levels in the central nervous system |
May. 11, 2004 |
| 6734168 |
Endothelial monocyte activating polypeptide II: a mediator which activates host response |
May. 11, 2004 |
| 6734169 |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
May. 11, 2004 |
| 6730659 |
Antimicrobial peptides and methods of use thereof |
May. 4, 2004 |
| 6727226 |
Mu-conopeptides |
Apr. 27, 2004 |
| 6723697 |
IL-16 antagonists |
Apr. 20, 2004 |
| 6723700 |
Compounds and methods for modulating claudin-mediated functions |
Apr. 20, 2004 |
| 6720305 |
Injectable formulations containing ramoplanin |
Apr. 13, 2004 |
| 6716428 |
Antigenic modification of polypeptides |
Apr. 6, 2004 |
| 6716809 |
Mage-A3 peptides presented by HLA class molecules |
Apr. 6, 2004 |
| 6716811 |
Compounds having affinity for the granulocyte-colony stimulating factor receptor (G-CSFR) and associated uses |
Apr. 6, 2004 |
| 6716816 |
Multimeric Apo A-I agonist compounds |
Apr. 6, 2004 |
| 6713057 |
Compositions and methods for modulating serum cholesterol |
Mar. 30, 2004 |
| 6713444 |
Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins |
Mar. 30, 2004 |
|
|
|
